Medical Countermeasures Tecovirimat Shown to Lack Efficacy as Treatment for Clade II MpoxMarch 12, 2025
Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical Countermeasures Medical Countermeasures March 18, 2025 Emergent BioSolutions today announced it has secured approximately $27 million in international orders targeted for delivery in 2025 associated with its…
Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresMarch 18, 2025
Tools for Dealing with Radiation Exposures: IARPA Invests $3.8M from TEI-REX ProgramSeptember 3, 2024
Preparedness HHS Provides Emergency Prescription Assistance for Californians Displaced by WildfiresGlobal Biodefense StaffJanuary 26, 2025
Impact of COVID-19 Pandemic on Emergency Department Use in British Columbia Health Security September 5, 2023
Distrust Undermined the U.S. Pandemic Response and Continues to Erode Healthcare Health Security August 29, 2023
HHS Provides Emergency Prescription Assistance for Californians Displaced by WildfiresJanuary 26, 2025
